Publication Name	World Journal of Clinical Cases
Manuscript ID	103239
Country	China

Received	2024-11-13 09:39
Peer-Review Started	2024-11-13 09:39
To Make the First Decision
Return for Revision	2024-12-12 08:11
Revised	2024-12-19 08:47
Second Decision	2025-01-09 02:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-01-09 10:02
Articles in Press	2025-01-09 10:02
Publication Fee Transferred	2024-12-24 05:07
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-01-15 08:13
Publish the Manuscript Online	2025-01-21 07:29

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Case Report
Article Title	Granulomatosis with polyangiitis induced by the anti-programmed cell death-1 inhibitor tislelizumab: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Jian-Hui Zhao, Jing-Jiao Wang and Yi-Wen Li
ORCID	Author(s) ORCID Number Jian-Hui Zhao http://orcid.org/0000-0002-6238-6776
Funding Agency and Grant Number
Corresponding Author	Jian-Hui Zhao, Associate Chief Physician, MD, Department of Nephrology, Xinchang County People's Hospital, No. 117 Gushan Middle Road, Nanming Street, Xinchang 312500, Zhejiang Province, China. lyzhaojh@126.com
Key Words	Tislelizumab; Programmed cell death-1 inhibitor; Granulomatosis with polyangiitis; Anti-neutrophil cytoplasmic antibody-associated vasculitis; Case report
Core Tip	Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) due to immune checkpoint inhibitors is extremely rare. AAV caused by the programmed cell death-1 inhibitor, tislelizumab, has not been reported. Our patient developed AAV and granulomatosis with polyangiitis after tislelizumab treatment. Glucocorticoids given in combination with cyclophosphamide effectively treated our patient. However, after the patient discontinued treatment without authorization, the vasculitis recurred. The glucocorticoid + cyclophosphamide regimen was continued, but the patient’s renal function deteriorated.
Publish Date	2025-01-21 07:29
Citation	<p>Zhao JH, Wang JJ, Li YW. Granulomatosis with polyangiitis induced by the anti-programmed cell death-1 inhibitor tislelizumab: A case report. <i>World J Clin Cases</i> 2025; 13(15): 103239</p>
URL	https://www.wjgnet.com/2307-8960/full/v13/i15/103239.htm
DOI	https://dx.doi.org/10.12998/wjcc.v13.i15.103239

Full Article (PDF)	WJCC-13-103239-with-cover.pdf
CARE Checklist–2016	103239-CARE-Checklist-2016.pdf
Manuscript File	103239_Auto_Edited_061316.docx
Answering Reviewers	103239-answering-reviewers.pdf
Audio Core Tip	103239-audio.mp3
Conflict-of-Interest Disclosure Form	103239-conflict-of-interest-statement.pdf
Copyright License Agreement	103239-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	103239-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	103239-non-native-speakers.pdf
Peer-review Report	103239-peer-reviews.pdf
Scientific Misconduct Check	103239-scientific-misconduct-check.png
Scientific Editor Work List	103239-scientific-editor-work-list.pdf
CrossCheck Report	103239-crosscheck-report.pdf